Skip to content
Back to Resources

Artificial Intelligence powered predictive analysis of atypical ductal hyperplasia from digitized pathology images

{"id":"block_63b60dfe3e32c","name":"acf\/block-resource-summary","data":{"resource_summary_0_summary_heading":"Study Background","resource_summary_0_summary_rich_text_module_0_content":"Approximately 15-25% of patients with atypical ductal hyperplasia (ADH) on breast core needle biopsy (CNB) are upgraded to ductal carcinoma in situ (DCIS) or invasive carcinoma (IC) on surgical excision.\r\n\u2022 We hypothesized that a machine learning approach could be utilized to train models to recognize ADH on digitized pathology images and to identify cases of ADH more likely to be upgraded to DCIS or IC at excision.\r\n\u2022 Here we demonstrate the accuracy of the machine learning approach to identify ADH.","resource_summary_0_summary_rich_text_module_0_button":"","resource_summary_0_summary_rich_text_module":1,"resource_summary_0_summary_document_link":"https:\/\/pathaiwp.wpenginepowered.com\/wp-content\/uploads\/2023\/01\/Copy-of-20191203_SABCS_Poster.FINAL_.pdf","resource_summary_0_summary_document_button_label":"View Poster","resource_summary_0_summary":"","resource_summary_0_author_heading":"Authors","resource_summary_0_author_rich_text_module_0_content":"Kerner et al.","resource_summary_0_author_rich_text_module_0_button":"","resource_summary_0_author_rich_text_module":1,"resource_summary_0_author":"","resource_summary":1,"jump_link_label":""},"align":"","mode":"edit"}
Get In Touch

Get In Touch

PathAI Media

Company Contact

Liz Storti

Chief People Officer

elizabeth.storti@pathai.com

Media Contact

Daniel Donato

LifeSci Communications

ddonato@lifescicomms.com

516-474-0554